Skip to content

Clinical trials

Lung Neoplasms trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Malaysia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20092
20152
20171
20181
20192
20214
20223
20232
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Terminated6
Active, not recruiting5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
AVEO Pharmaceuticals, Inc.1
Arcus Biosciences, Inc.1
ArriVent BioPharma, Inc.1
AstraZeneca1
Bioven Sdn. Bhd.1
Bristol-Myers Squibb1
Checkpoint Therapeutics, Inc.1
Formycon AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms27
Carcinoma, Non-Small-Cell Lung22
Neoplasms4
Lung Diseases3
Respiratory Tract Neoplasms3
Bronchial Neoplasms2
Carcinoma2
Neoplasm Metastasis2
Neoplasms by Site2
Respiratory Tract Diseases2

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.